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Vitamin D Production after UVB Exposure Depends
on Baseline Vitamin D and Total Cholesterol but Not
on Skin Pigmentation
Morten K.B. Bogh1, Anne V. Schmedes2, Peter A. Philipsen1, Elisabeth Thieden1 and Hans C. Wulf1
UVB radiation increases serum vitamin D level expressed as 25-hydroxyvitamin-D3 (25(OH)D), but the influence
of skin pigmentation, baseline 25(OH)D level, and total cholesterol has not been well characterized. To
determine the importance of skin pigmentation, baseline 25(OH)D level, and total cholesterol on 25(OH)D
production after UVB exposure, 182 persons were screened for 25(OH)D level. A total of 50 participants with a
wide range in baseline 25(OH)D levels were selected to define the importance of baseline 25(OH)D level. Of
these, 28 non-sun worshippers with limited past sun exposure were used to investigate the influence of skin
pigmentation and baseline total cholesterol. The participants had 24% of their skin exposed to UVB (3 standard
erythema doses) four times every second or third day. Skin pigmentation and 25(OH)D levels were measured
before and after the irradiations. Total cholesterol was measured at baseline. The increase in 25(OH)D level after
UVB exposure was negatively correlated with baseline 25(OH)D level (Po0.001) and positively correlated with
baseline total cholesterol level (P¼ 0.005), but no significant correlations were found with constitutive or
facultative skin pigmentation. In addition, we paired a dark-skinned group with a fair-skinned group according
to baseline 25(OH)D levels and found no differences in 25(OH)D increase after identical UVB exposure.
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INTRODUCTION
Vitamin D insufficiency (25-hydroxyvitamin D3 (25(OH)D)
o50 nmol l1) is common and is related to rachitis and
osteoporosis, and may increase the risk of some internal
malignancies and autoimmune diseases (Chapuy et al., 1992;
Ahonen et al., 2000; Munger et al., 2004; Ponsonby et al.,
2005; Kemp et al., 2007). UV radiation of the skin provides
90–95% of the total vitamin D requirements for the majority
of the population (Holick, 1998, 2004).
Solar UV radiation (290–400 nm) comprises 90–100%
UVA (320–400 nm) and 0–10% UVB (280–320 nm). The
action spectrum for cutaneous pre-vitamin D3 synthesis
shows that only UVB radiation initiates synthesis (CIE 174
Technical Report, 2006). Conversely, it is also mainly UVB
that causes sunburn and carcinogenesis (Diffey, 2002).
Despite the risk of skin cancer, sun exposure is often
recommended to avoid vitamin D insufficiency (Holick,
2008; Moan et al., 2008); and this has led to scientific debate
(Samanek et al., 2006; Gilchrest, 2008).
Studies suggest a faster vitamin D production among
individuals with a very low vitamin D level (Viljakainen
et al., 2006; Binkley et al., 2007; Brustad et al., 2007;
Edvardsen et al., 2007), and skin pigmentation is generally con-
sidered to diminish vitamin D production from sun exposure
(Holick et al., 1981; Clemens et al., 1982; Chen et al., 2007).
However, these theories are not well documented (Young,
2006). Furthermore, cholesterol and vitamin D share the 7-
dehydrocholesterol pathway (Slominski et al., 2004; Champe
et al., 2005), and may therefore be interdependent. We
therefore sought to define the importance of skin pigmentation,
baseline 25(OH)D levels, and total cholesterol level on the
vitamin D production after UVB exposure.
RESULTS
The initial screening of 182 persons
Of 182 persons screened for serum 25(OH)D level in January
(Figure 1), 67% were vitamin D insufficient (25(OH)D
o50 nmol l1) and 18% were vitamin D deficient
(25(OH)D p25 nmol l1). Three groups were selected for
further analyses (Figure 2).
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Group 1: 50 participants with a wide range in baseline
25(OH)D levels
When the influence of baseline 25(OH)D level on vitamin D
production after exposure to UVB radiation was examined,
50 participants (Table 1) with all levels of 25(OH)D due
to previous different sun exposures were included: 25
with an insufficient 25(OH)D level (evenly distributed
25–50 nmol l1), 15 with a deficient 25(OH)D level
(p25 nmol l1), and 10 with a highly sufficient 25(OH)D
level (470 nmo l1). As the level of baseline 25(OH)D is
expected to be of importance to the baseline parathyroid
hormone (PTH) level, this was also examined in this group.
The 25(OH)D (mean (standard deviation, SD)) level
increased by 23.3 nmol l1 (10.6) in response to the UVB
treatments, with a strong negative correlation between the
increase in 25(OH)D (D25(OH)D) and baseline 25(OH)D
levels (Po0.001; R2¼0.313, Figure 3).
We found a significant negative correlation between
baseline 25(OH)D and baseline PTH levels (P¼0.025;
R2¼ 0.104, Figure 4), but we found no significant correla-
tions between baseline 25(OH)D level and body mass index.
However, we found a positive linear relation between
baseline 25(OH)D levels and the number of fish meals per
week (P¼0.009; R2¼ 0.132), with the baseline 25(OH)D
level being 12 nmol l1 higher in the group eating fish more
than once a week.
As expected, the facultative skin pigmentation (pigment
protection factor (PPF) upper body) increased from (mean
(SD)) 6.5 (2.9) to 7.9 (3.0) (Po0.001), and the skin redness
percent increased from (mean (SD)) 22.8 (6.6) to 25.5 (7.4)
(P¼0.004) after the UVB treatments.
Group 2: a homogeneous population of 28 non-sun worshippers
A homogeneous population of 28 non-sun worshippers
(group 2) (Table 1) with limited past sun exposure were
selected from the 50 participants (group 1) and 22 sun
worshippers with excessive and very different sun exposure
were excluded (Figure 2). We found a significant difference in
baseline 25(OH)D level (P¼0.018) between the 28 non-sun
worshippers and the 22 sun worshippers due to different
amounts of previous sun exposure.
In the selected 28 non-sun worshippers (group 2), 25(OH)D
levels increased by (mean (SD)) 25.3 nmol l1 (10.5) in
response to the UVB treatments. No significant correlations
were found between D25(OH)D and constitutive (PPF buttock)
(P¼ 0.5) or facultative (P¼ 0.4) skin pigmentation. However,
we found a significant positive correlation between D25(OH)D
and baseline total cholesterol, the precursor of vitamin D
(P¼ 0.005; R2¼ 0.265, Figure 5). Furthermore, we found a
significant relation between D25(OH)D and sex, as 25(OH)D
(mean (SD)) increased by 20.6 nmol l1 (13.3) among female
participants compared with 28.8 nmol l1 (6.0) among male
participants (P¼0.01). There were no significant relations
between D25(OH)D and age, height, weight, numbers of fish
meals per week, body mass index, PTH, alkaline phosphatase,
ionized calcium, or skin redness percent after exposure. The
facultative skin pigmentation increased from (mean (SD)) 7.1
(3.5) to 8.8 (3.5) (Po0.001), and the skin redness percent
increased from (mean (SD)) 21.8 (7.2) to 24.2 (6.8) (P¼ 0.027)
during the course of UVB treatments.
Group 3: nine matched pairs
A total of 18 participants (group 3) (Table 1) consisting of 9
pairs of dark- (skin types V–VI (Fitzpatrick, 1988)) and fair-
skinned participants (skin types I–IV (Fitzpatrick, 1988)) were
matched according to ‘‘identical’’ baseline 25(OH)D levels
(Table 2). They were used to confirm whether constitutive or
facultative skin pigmentation has a role for D25(OH)D after
UVB exposure. We found no significant differences in
D25(OH)D (P¼0.7) between the dark- and the fair-skinned
group despite their significant difference in constitutive and
facultative skin pigmentation (P¼0.008).
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Figure 1. Distribution of 25(OH)D levels for the 182 participants at the
initial screening. 67% Of participants were vitamin D insufficient
(25(OH)Do50 nmol/l), and 18% were vitamin D deficient
(25(OH)Dp25 nmol/l). The dark and light grey lines show cutoffs
at 25 nmol/l and 50 nmol/l, respectively.
182 Persons were screened
for 25(OH)D level
Group 1:
50 Participants with a wide range in 25(OH)D level due to
differences in past sun exposure were selected when analyzing
the influcence of baseline 25(OH)D
Group 2:
A homogeneous group of 28 non-sun worshippers with limited past
sun exposure were selected when analyzing the influcence of skin
pigmentation, baseline total cholesterol, and other parameters
Group 3:
Nine pairs of fair- and dark-skinned participants 
matched according to baseline 25(OH)D were selected 
to confirm the influence of skin pigmentation
Figure 2. Flowchart describing the selection and purpose of selecting the
3 groups.
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Table 1. Participants baseline characteristics1
Group 1: 50 participants with a
wide range in baseline 25(OH)D
Group 2: a homogeneous population
of 28 non-sun worshippers
Group 3: nine
matched pairs
Number of participants 50 28 18
Number of males 21 16 11
Number of females 29 12 7
Number of skin type I2 4 4 2
Number of skin type II 15 5 2
Number of skin type III 9 4 2
Number of skin type IV 12 5 3
Number of skin type V 7 7 7
Number of skin type VI 3 3 2
PPF—buttock3 5.9±3.5 (1.5–18.7) 6.5±4.4 (1.5–18.7) 7.1±4.1 (1.5–17.4)
PPF—upper body4 6.5±2.9 (1.7–17.7) 7.1±3.5 (1.7–17.7) 7.8±3.8 (1.7–17.7)
Skin redness, percent 22.8±6.6 (2.2–34.7) 21.8±7.2 (2.2–33.9) 20.0±8.4 (2.2–33.9)
Age 31.0±8.1 (19–48) 31.0±7.5 (19–48) 41.3±8.3 (19–48)
Weight, kg 76.6±16.5 (55–120) 78.9±17.5 (55–120) 78.9±16.0 (55–120)
Height, m 1.74±0.1 (1.56–1.96) 1.75±0.1 (1.56–1.89) 1.74±0.1 (1.56–1.89)
Body mass index, kg m2 25.1±4.7 (19.2–40.8) 25.8±4.8 (19.2–37.0) 26.0±4.4 (20.0–37.0)
Serum 25(OH)D, nmol l1 36.5±26.5 (5–116) 27.8±18.0 (5–88) 20.3±8.9 (9–41)
Serum PTH, rmol l1 4.4±2.1 (0.7–12.0) 4.8±2.5 (0.7–12.0) 5.5±2.5 (2.8–12.0)
Serum ionized calcium, mmol l1 1.22±0.03 (1.16–1.30) 1.22±0.03 (1.16–1.30) 1.21±0.03 (1.16–1.26)
Serum alkaline phosphatase, U l1 68±15.5 (32–106) 72.4±13.4 (49–106) 70.2±13.5 (49–106)
Serum total cholesterol, mmol l1 5.0±0.9 (3.6–8.0) 4.7±0.7 (3.6–6.3) 4.8±0.5 (3.7–5.5)
25(OH)D, 25-hydroxyvitamin-D3; PPF, pigmentation protection factor.
1Mean±SD (range).
2Fitzpatrick, 1988.
3Constitutive skin pigmentation.
4Facultative skin pigmentation.
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Figure 3. Relationship between the increase in vitamin D (D25(OH)D) and
baseline 25(OH)D among the 50 participants (group 1) (P=0.000024;
R2=0.313).
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Figure 4. Relationship between baseline 25(OH)D and baseline parathyroid
hormone (PTH) level (group 1) (P¼ 0.025; R2¼0.104; 48 participants
were included, 2 outliers outside 3 standard deviations excluded).
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DISCUSSION
In total, 67% of the 182 participants had 25(OH)D levels
below 50 nmol l1, and 18% were below 25 nmol l1. The
recommended level of 25(OH)D is estimated to be
50 nmol l1 or higher (Brot et al., 2001; Lips, 2004;
Mosekilde et al., 2005). However, it is debated whether
higher 25(OH)D levels of 80–100 nmol l1 are preferable
(Holick, 1998; Heaney, 2005; Vieth, 2006).
To strengthen our findings, we included detailed informa-
tion on lifestyle factors, collected information on intakes of
calcium and vitamin D, included two serum samples from
each subject, measured pigmentation, and conducted the
study when the ambient UV radiation was negligible and
the blood concentration of vitamin D was considered as the
year’s lowest in Denmark 561N. Furthermore, we selected a
homogeneous population of 28 non-sun worshippers
(group 2) with limited past sun exposure, because differences
in sun habits is a confounding factor when analyzing the
influence of skin pigmentation, baseline total cholesterol, and
other parameters except the influence of baseline 25(OH)D
levels for which a wide range of baseline 25(OH)D levels are
needed. UVB radiation was used as it fits the vitamin D action
spectrum and uniform irradiation of large body surface areas
can be obtained. A limitation of this study was the relatively
small sample size, especially in the dark-skinned group.
Furthermore, we found a high variance in the liquid chromato-
graphy-tandem mass spectrometry analysis of 25(OH)D of
B8.5%, despite including two serum samples from each
subject and performing each 25(OH)D analysis twice.
Among the 50 participants in group 1, we found a
significantly higher 25(OH)D production after UVB exposure
in participants with a low baseline 25(OH)D level. Although
not specifically exploring the mechanism, several studies
have reported that individuals with low baseline vitamin D
are the most effective at increasing serum levels of vitamin D
after UVB exposure (Viljakainen et al., 2006; Binkley et al.,
2007; Brustad et al., 2007; Edvardsen et al., 2007;
Stephenson et al., 2007; Carbone et al., 2008). The reasons
for this are unknown, but it may be because 25(OH)D inhibits
25-hydroxylase in the liver; the liver prompts hydroxylation
of vitamin D3 to 25(OH)D (Champe et al., 2005).
Among the 28 non-sun worshippers in group 2, we found
no significant relation between D25(OH)D and constitutive
or facultative skin pigmentation. Furthermore, Table 2 shows
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Figure 5. Relationship between the increase in vitamin D (D25(OH)D) and
baseline total cholesterol in the 28 non-sun worshippers (group 2) with
limited past sun exposure (P¼ 0.005; R2¼ 0.265).
Table 2. PPF buttock and upper body and D25(OH)D for nine dark-skinned participants (skin types V–VI) and nine
fair-skinned participants (skin types I–IV) matched according to baseline 25(OH)D level1 (group 3)
PPF buttock2 PPF upper body3 Baseline 25OH(D), nmol l1 D25OH(D), nmol l1
Pair Dark4 Fair5 Dark Fair Dark Fair Dark Fair
1 11.9 7.6 12.6 8.6 10.3 9.4 30.0 25.7
2 13.0 3.8 10.8 5.7 11.9 14.7 24.6 35.7
3 17.4 2.0 17.7 3.4 12.8 16.0 16.7 25.5
4 8.6 3.2 6.8 4.1 13.3 17.6 13.2 29.3
5 9.1 1.5 9.0 1.7 17.3 22.0 40.1 38.0
6 6.6 4.0 7.4 6.7 18.6 22.1 37.9 27.7
7 9.6 5.2 12.6 5.6 24.1 24.6 32.2 18.2
8 5.7 4.0 7.6 4.9 25.6 26.0 31.7 22.5
9 8.6 5.2 9.3 6.4 41.1 39.0 2.0 19.5
Mean (±SD) 10.1 (3.6) 4.1 (1.8) 10.4 (3.5) 5.2 (2.0) 19.4 (9.7) 21.3 (8.5) 24.9 13.5) 26.9 (6.7)
P-value 0.008 0.008 0.07 0.7
25(OH)D, 25-hydroxyvitamin-D3; PPF, pigmentation protection factor.
1Wilcoxon signed rank test was used in the paired test.
2Constitutive skin pigmentation.
3Facultative skin pigmentation.
4Dark-skinned, non-ethnic Danish participants, skin types V–VI (Fitzpatrick, 1988).
5Fair-skinned, ethnic Danish participants, skin types I–IV (Fitzpatrick, 1988).
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no significant differences in D25(OH)D between the dark-
skinned persons and the 25(OH)D baseline-matched fair-
skinned persons (group 3) despite their highly significant
difference in constitutive and facultative skin pigmentation.
This shows that D25(OH)D is unrelated to skin pigmentation.
A number of very small studies in vitro (Holick et al., 1981)
and in vivo (Clemens et al., 1982; Chen et al., 2007) indicate
that melanin pigmentation diminish vitamin D production in
the skin.
Conversely, Brazerol et al. (1988) found a similar vitamin
D increase in a fair-skinned group (n¼ 13) compared with a
dark-skinned group (n¼7) exposed to suberythemal whole-
body UVR twice a week for 6 weeks. Furthermore, a study of
Rockell et al. (2008) found that only facultative skin color is a
determinant of vitamin D production and claims that
constitutive skin type is of no significant importance. In
addition, Marks et al. (1995) reported no significant relations
between skin type and vitamin D production. There is an
obvious lack of agreement about the role of skin pigmenta-
tion in vitamin D production after UVB exposure, and skin
pigmentation was not measured in any of the studies.
However, several studies have reported a lower level of
vitamin D among dark-skinned than among fair-skinned
individuals (Harris and Dawson-Hughes, 1998; Nesby-
O’Dell et al., 2002), and it might be possible that vitamin
D insufficiency among certain ethnic groups results from
other factors than skin pigmentation such as behavior or diet.
We found a remarkable difference in sun habits between
the dark-skinned group, who were non-sun worshippers with
limited levels of sun exposure, and the fair-skinned group, in
which the main part was sun worshippers with excessive
levels of sun exposure. These differences in sun habits may
explain why dark-skinned persons are reported to have lower
vitamin D levels than fair-skinned persons (Harris and
Dawson-Hughes, 1998; Nesby-O’Dell et al., 2002, Young,
2006). Although we found no differences in vitamin D
formation between dark- and fair-skinned persons during
wintertime, when melanin is located in the basal layers of
epidermis, a relation could exist in the summertime, when
melanin moves further up in epidermis due to sun exposure.
Another explanation could be that 3 standard erythema doses
(SEDs) administered four times to 24% of the body surface
area is sufficient to reach a state of saturation.
Notably, we also found a significant positive relation
between D25(OH)D and baseline total cholesterol levels. The
synthesis of vitamin D starts in the bowel epithelial with the
oxidation of cholesterol from food or bile to pro-vitamin D3
(7-dehydrocholesterol), which is then transported to the skin,
mainly the epidermis, wherein it is isomerized to pre-vitamin
D3 (cholecalciferol) by UVB radiation (Champe et al., 2005).
A recent study also reports a significant positive relation
between baseline vitamin D and total cholesterol level
(Pe´rez-Castrillo´n et al., 2007). However, there is no indica-
tion of a fall in vitamin D status after statin therapy (Dobs
et al., 1991; Pe´rez-Castrillo´n et al., 2007). Statin therapy
inhibits the enzyme hydroxymethylglutaryl-CoA (HMG-CoA)
reductase (Champe et al., 2005), which is believed to
increase the level of 7-dehydrocholesterol, a precursor of
vitamin D (Pe´rez-Castrillo´n et al., 2007). It should be noted
that none of the participants in our study had any intake of
cholesterol-lowering medicine.
Our study shows that both fair-skinned and dark-skinned
persons without any underlying medical condition should be
able to produce sufficient vitamin D from a few low doses of
UVB (3 SEDs are equivalent toB30 minutes of sun exposure
in the middle of a clear summer day in Denmark, 561N).
However, due to its skin-carcinogenic effect, we would not
recommend UVB treatment to be used as a source of vitamin
D to the general population, because sufficient vitamin D
levels can be re-established with vitamin D supplements
(Gilchrest, 2007; Hathcock et al., 2007; Thieden et al., 2008).
In conclusion, we found that baseline vitamin D level is an
important determinant of vitamin D production after UVB
treatment. We also found that constitutive or facultative skin
pigmentation in winter is of no importance for the vitamin D
production in the skin. Furthermore, this study revealed a
relation between total cholesterol and vitamin D production,
indicating that a low natural cholesterol level might be
problematic.
MATERIALS AND METHODS
Design
This is an open and controlled clinical trial, conducted at Bispebjerg
University Hospital, Denmark 561N, from January to March 2008,
when the ambient UVB radiation is negligible and the low outdoor
temperature prohibits solar exposure, apart from the hands and face.
The participants were recruited by advertising on websites between
December 2007and January 2008.
Participants and procedure
The initial screening of 182 persons. We screened 182 healthy
persons (106 women and 76 men, mean age 29.8 years, range 18–51
years) for 25(OH)D level in January and February to find a suitable
population of participants with a wide range of baseline 25(OH)D
levels (Figure 1) and a wide variation in skin pigmentation. Vitamin
D sufficiency is defined as 25(OH)D levels X50 nmol l1, vitamin D
insufficiency as 25(OH)D levels o50 nmol l1, and vitamin D
deficiency as 25(OH)D levels p25 nmol l1.
Group 1: 50 participants with a wide range in baseline
25(OH)D levels. We selected 50 participants (Table 1) with
different levels of baseline 25(OH)D: 25 with 25(OH)D levels evenly
distributed from 25 to 50 nmol l1, 15 with 25(OH)D o25 nmol l1,
and 10 with 25(OH)D 470 nmo l1 (Figure 2). All participants
completed a standardized questionnaire that ascertained demo-
graphic characteristics, chronic diseases, medication, dietary sup-
plements, sun habits, sun holidays, sun-bed use, and other lifestyle
variables that could cause differences in vitamin D level. Weight and
height were recorded and the body mass index was calculated. All 50
participants were used for the investigation of the influence of baseline
25(OH)D level on vitamin D production after UVB radiation.
Group 2: a homogeneous population of 28 non-sun
worshippers. By a questionnaire about sun habits, it was possible
to subdivide the 50 participants (group 1) into 28 non-sun worshippers
(group 2) and 22 sun worshippers. The non-sun worshippers were
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defined as persons who preferred to sit in the shadow, did not sunbathe
(without clothes), and reported limited sun exposure the previous
summer. The sun worshippers were defined as persons who preferred
to sit in the sun (with clothes), preferred to sunbathe (without clothes),
and reported excessive sun exposure the previous summer. The 28 non-
sun worshippers were considered to be a relatively homogeneous
population and were therefore included in the analysis of the influence
of skin pigmentation, cholesterol, and other variables. Uncontrollable
sun exposure the previous summer is a confounding factor when
analyzing these parameters.
Group 3: nine matched pairs. A total of 18 participants (Table 1)
consisting of 9 pairs of dark- (skin types V–VI (Fitzpatrick, 1988)) and
fair-skinned participants (skin types I–IV (Fitzpatrick, 1988)) were
selected from group 2. The nine pairs were matched according to
‘‘identical’’ baseline 25(OH)D levels (Table 2), and the group was
created to confirm the lack of relation between skin pigmentation
and vitamin D production found in group 2.
Inclusion criteria. Inclusion criteria for all participants were:
(1) age 18–51 years; (2) willingness to avoid sun-bed exposure;
(3) holidaying south of 451 latitude after 1 November 2007; and
(4) avoiding supplementation of vitamin D 2 months before the study
and during the study period.
Exclusion criteria. The participants were not admitted to the study
if they had (1) sun-bed use or holidays in sunny countries (at latitudes
below 451) after 1 November 2007; (2) supplementary vitamin D
ingestion above the level in a multivitamin tablet (10 mg per day); (3)
skin disease; (4) psychological disease; (5) drug addiction; (6) intake
of medication which causes photosensitive skin; (7) intake of
cholesterol-lowering medicine; or (8) if they were pregnant.
Ethics. The ethics committee approved the study protocol (H-B-
2007–100) and the study was carried out in accordance with the
Declaration of Helsinki. All participants gave a written informed consent.
Skin type, skin pigmentation, and skin redness percent
To follow skin response to the UVB radiation, the redness percent
and PPF was measured on the back, abdomen, and buttocks at
baseline and before every UVB session by a skin reflectance meter
(UV-Optimize, Scientific, Chromo-light, Espergaerde, Denmark,
measuring range 1.0–24.0 (Wulf, 1986)). Self-reported skin type
according to Fitzpatrick was also registered at baseline (Fitzpatrick,
1988). PPF is objectively measured skin type (predicted number of
SED to MED (minimal erythema dose)).
Irradiation
A broadband UVB radiation source consisting of a bank of Philips
TL12 tubes (280–350 nm, Philips, Eindhoven, The Netherlands) was
used for irradiation (Figure 6). The UV source could irradiate all
body surface areas with equal intensity. The UV-intensity was
controlled weekly during the treatment period using a Sola-Hazard
spectroradiometer (Solatell, Cornwall, UK). The participants had four
UVB exposures to the chest and back (24% body surface (Augustsson
et al., 1992)). Each exposure of 3 SEDs (equivalent to a physical
dose of 109.8 mJ cm2) was given during 10 minutes with 2 or
3 days’ interval (that is: Mon, Wed, Fri, Mon). 1 SED is defined as
10 mJ cm2 at 298 nm using CIE (Commission on the Environment)
erythema action spectrum and it is the UV dose that elicits just
perceptible erythema in the most sensitive person in a group of very
sun-sensitive healthy persons (Lock-Andersen et al., 1996).
Biochemical analyses
Blood samples were analyzed at baseline for ionized calcium,
parathyroidea hormone, alkaline phosphatase, total cholesterol, and
25(OH)D. 25(OH)D levels were both measured at baseline and at
2 days after the fourth and last UVB session. The blood samples were
taken by venipuncture and were centrifuged (5,000 g in 10 min-
utes) within 2 hours of sampling.
Vitamin D. The serum samples for 25(OH)D analysis were frozen,
stored at 80 1C, and sent on dry ice to the biochemical laboratory
for 25(OH)D analysis by liquid chromatography-tandem mass
spectrometry. To minimize the variance of 25(OH)D, two serum
samples from each subject were included and each 25(OH)D
analysis was performed twice. The analysis was calibrated with five
in-house-prepared calibrators. The total relative SD for double
determinations was 8.5% and the interseries relative SD were 14.1%
at 20 nmol l1, 4.4% at 50 nmol l1, and 4.9% at 222 nmol l1.
Parathyroid hormone. Serum PTH was determined on Immulite
2500 biochemistry analyzer (Diagnostic Products Corporation, Los
Angeles, CA). It is based on a chemiluminescence immunometric
assay with a detection limit of 0.3 pmol l1 and is specific for PTH.
The intraseries variance is 15.0% at the 2.4 pmol l1 level, 10% at
6.3 pmol l1, and 12.0% at 22.8 pmol l1.
Ionized calcium. Ionized calcium was measured in serum on an
ABL700 blood gas analyzer (Radiometer a/s, Brønshøj, Denmark)
using the E733 ion-selective electrode. The intraseries variance is
0.7% and the interseries variance is 1.2% at 1.6 mmol l1.
Alkaline phosphatase. Serum alkaline phosphatase was measu-
red on a VITROS 5.1 FS (Ortho Clinical Diagnostics, Raritan,
NJ) using VITROS ALKP slides and VITROS calibrator kit 3.
The intraseries variance is 1.8% and the interseries variance
is 1.5% at 107 U l1.
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Figure 6. Red line: UV spectrum for a TL 12 UV lamp. Blue line: Action
spectrum for the production of pre-vitamin D3 in humans (CIE 174 Technical
Report, 2006). Green line: CIE pre-vitamin D3 weighted UV action spectrum
of the TL 12 UV lamp.
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Total cholesterol. Serum total cholesterol was measured on a
VITROS 5.1 FS (Ortho Clinical Diagnostics, Raritan, NJ) using
VITROS slides methods and VITROS calibrator kit 2. The intraseries
variance is 1.1% and the interseries variance is 1.6% at
3.7 mmol l1.
Statistical analysis
The data were statistically handled using SPSS 17.0 for Windows
(SPSS, Chicago, IL). The relationship between D25(OH)D and sex,
age, height, weight, number of fish meals per week, body mass
index, baseline 25(OH)D level, biochemical parameters, PPF, and
redness percent was examined using multiple linear regression
analysis with all independent variables entered into a forward
model. Comparing D25(OH)D and sex, we used Mann–Whitney test.
Comparing the dark-skinned group with the fair-skinned group
(matched pairs) according to baseline 25(OH)D level, we used
Wilcoxon signed rank test. The significance limit was Po0.05. Data
were considered outliers if they were outside 3 SD of the regression
line.
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